Red cell alloimmunization: A 2020 update
| Autor: | Mark D. Kilby, James S. Castleman |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Blood Transfusion Intrauterine 030105 genetics & heredity Rh Isoimmunization History 21st Century Erythroblastosis Fetal 03 medical and health sciences 0302 clinical medicine Fetal anemia Pregnancy Humans Medicine Intensive care medicine Fetal therapy Genetics (clinical) 030219 obstetrics & reproductive medicine Red Cell business.industry Obstetrics and Gynecology Prenatal Care medicine.disease Fetal Diseases Current management Prenatal Exposure Delayed Effects Female business |
| Zdroj: | Prenatal Diagnosis. 40:1099-1108 |
| ISSN: | 1097-0223 0197-3851 |
| DOI: | 10.1002/pd.5674 |
| Popis: | Management of maternal red cell alloimmunization has been revolutionized over the last 60 years. Advances in the prevention, screening, diagnosis, and treatment of alloimmune-induced fetal anemia make this condition an exemplar for contemporary practice in fetal therapy. Since survival is now an expectation, attention has turned to optimization of long-term outcomes following an alloimmunized pregnancy. In this review, the current management of red cell alloimmunization is described. Current research and future directions are discussed with particular emphasis on later life outcomes after alloimmune fetal anemia. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text